For: | Noll ATR, Cramer T, Olde Damink SWM, Schaap FG. Cholangiocarcinoma, gone without the Wnt? World J Hepatol 2016; 8(26): 1093-1096 [PMID: 27660676 DOI: 10.4254/wjh.v8.i26.1093] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i26/1093.htm |
Number | Citing Articles |
1 |
Shuai He, Shilei Tang. WNT/β-catenin signaling in the development of liver cancers. Biomedicine & Pharmacotherapy 2020; 132: 110851 doi: 10.1016/j.biopha.2020.110851
|
2 |
Adrian P. Mansini, Estanislao Peixoto, Kristen M. Thelen, Cesar Gaspari, Sujeong Jin, Sergio A. Gradilone. The cholangiocyte primary cilium in health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1245 doi: 10.1016/j.bbadis.2017.06.006
|
3 |
Rita Manco, Isabelle A. Leclercq, Laure-Alix Clerbaux. Liver Regeneration: Different Sub-Populations of Parenchymal Cells at Play Choreographed by an Injury-Specific Microenvironment. International Journal of Molecular Sciences 2018; 19(12): 4115 doi: 10.3390/ijms19124115
|
4 |
Yongqin Ye, Vincent Chi Hang Lui, Paul Kwong Hang Tam. Pathogenesis of Choledochal Cyst: Insights from Genomics and Transcriptomics. Genes 2022; 13(6): 1030 doi: 10.3390/genes13061030
|
5 |
Guo-Feng Zhang, Ling Qiu, Shu-Li Yang, Jia-Cheng Wu, Tong-Jun Liu. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma. Bioscience Reports 2020; 40(3) doi: 10.1042/BSR20193353
|
6 |
Norma Pangestu, Piyasiri Chueakwon, Krajang Talabnin, Juthamas Khiaowichit, Chutima Talabnin. RNF43 overexpression attenuates the Wnt/β‑catenin signalling pathway to suppress tumour progression in cholangiocarcinoma. Oncology Letters 2021; 22(6) doi: 10.3892/ol.2021.13107
|
7 |
Fei Chen, Jian Sheng, Xiaoping Li, Zhaofeng Gao, Lingyu Hu, Minjie Chen, Jianguo Fei, Zhengwei Song. Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1451474
|